These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Blood flow in the isovolumetric relaxation phase in heart transplant patients. Its use in the noninvasive diagnosis of acute rejection]. Derumeaux G; Mouton-Schleifer D; Redonnet M; Cribier A; Soyer R; Letac B Arch Mal Coeur Vaiss; 1998 Jun; 91(6):731-8. PubMed ID: 9749189 [TBL] [Abstract][Full Text] [Related]
24. High-sensitivity cardiac troponin I assay to screen for acute rejection in patients with heart transplant. Patel PC; Hill DA; Ayers CR; Lavingia B; Kaiser P; Dyer AK; Barnes AP; Thibodeau JT; Mishkin JD; Mammen PP; Markham DW; Stastny P; Ring WS; de Lemos JA; Drazner MH Circ Heart Fail; 2014 May; 7(3):463-9. PubMed ID: 24733367 [TBL] [Abstract][Full Text] [Related]
26. Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection. Wilhelm MJ; Pratschke J; Beato F; Taal M; Laskowski IA; Paz DM; Schmid C; Hancock WW; Scheld HH; Tilney NL Transplant Proc; 2002 Sep; 34(6):2359-60. PubMed ID: 12270436 [No Abstract] [Full Text] [Related]
27. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients. Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429 [TBL] [Abstract][Full Text] [Related]
28. Prediction of heart transplant rejection with a breath test for markers of oxidative stress. Phillips M; Boehmer JP; Cataneo RN; Cheema T; Eisen HJ; Fallon JT; Fisher PE; Gass A; Greenberg J; Kobashigawa J; Mancini D; Rayburn B; Zucker MJ Am J Cardiol; 2004 Dec; 94(12):1593-4. PubMed ID: 15589029 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Vivekananthan K; Kalapura T; Mehra M; Lavie C; Milani R; Scott R; Park M Am J Cardiol; 2002 Sep; 90(5):517-20. PubMed ID: 12208413 [TBL] [Abstract][Full Text] [Related]
30. Extended experience and subgroup analysis using cardiac troponin T for rejection monitoring after heart transplantation. Gleissner CA; Zehelein J; Sack FU; Schnabel P; Haass M; Dengler TJ Transplant Proc; 2002 Sep; 34(6):2178-80. PubMed ID: 12270356 [No Abstract] [Full Text] [Related]
32. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227 [TBL] [Abstract][Full Text] [Related]
33. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients. Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Hübler M; Abd El Rahman MY; Miera O; Ewert P; Weng Y; Wei H; Krüdewagen B; Hetzer R; Berger F J Heart Lung Transplant; 2006 Jun; 25(6):619-25. PubMed ID: 16730566 [TBL] [Abstract][Full Text] [Related]
34. Persistent histologic evidence of rejection in a heart transplant recipient without evidence of graft dysfunction. Nakhleh RE; Kubo SH; Olivari MT; McDonald K J Heart Lung Transplant; 1992; 11(1 Pt 1):37-41. PubMed ID: 1540610 [No Abstract] [Full Text] [Related]